Evidence map›Paper›PMID 17493021›Full record

ArticleClinical and experimental immunology2007

Antibody CR1-2B11 recognizes a non-polymorphic epitope of human CR1 (CD35).

C-H Chen, I Ghiran, F J M Beurskens, G Weaver, J A Vincent, A Nicholson-Weller, L B Klickstein

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

C-H ChenDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA.
I Ghiran
F J M Beurskens
G Weaver
J A Vincent
A Nicholson-Weller
L B Klickstein
Brigham and Women's Hospital · USBeth Israel Deaconess Medical Center · US

Funding

CRI (CD35) As a Cellular Receptor for CIqR01AI042987 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI NICHOLSON-WELLER, ANNE · 1998 to 2007
$2.8M
THE REGULATION OF BETA-2 INTEGRIN FUNCTIONR01AR047243 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI KLICKSTEIN, LLOYD B · 2000 to 2004
$1.2M
Neutrophil ecto-Calreticulin: Implications for ImmunityR21AI057983 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GHIRAN, IONITA CALIN · 2004 to 2005
$510k
NIAID NIH HHS R01 AI042987NIAID NIH HHS R01 AI42987NIAID NIH HHS R21 AI057983NIAMS NIH HHS R01 AR047243
6 · The paper itself

Abstract

Measurement of erythrocyte [red blood cells (RBC)] complement receptor type 1 (CR1, CD35) has the potential to serve as a sensitive assessment of complement activation and immune complex clearance. All previously reported monoclonal antibodies (MoAb) to the extracellular region of CR1 recognize epitopes within the long homologous repeats (LHR) of CR1 and the epitopes for the most frequently used MoAbs are repeated at least twice per CR1 molecule. Furthermore, CR1 exhibits structural polymorphism characterized by a variable number of LHR per molecule. Thus, accurate enumeration of cell surface CR1 using currently available MoAb would require that the results be corrected for the number of antibody epitopes per CR1 molecule encoded by each individual's alleles. To obtain a MoAb to a non-polymorphic epitope on human CR1, hybridomas were generated from mice immunized with recombinant soluble CR1 (sCR1) and MoAb were screened for those that recognized the full-length extracellular domain but failed to bind to all four recombinant LHR fragments. A single antibody, CR1-2B11, was identified and was found to recognize an epitope located wholly within SCR29-30 of CR1, NH2-terminal to an elastase cleavage site. Like other CR1 MoAb, the CR1-2B11 epitope expression decreased on old erythrocytes compared to younger cells and CR1-2B11 did not identify a CR1 'stump' on RBC. Importantly, CR1-2B11 immunofluorescence did not change with storage or handling of RBC, unlike the apparent decrease in immunofluorescence observed with other MoAb. CR1-2B11 should be useful for the accurate enumeration of RBC CR1.

Indexed as

AnimalsAntibodies, MonoclonalBlotting, WesternCellular SenescenceCHO CellsCricetinaeCricetulusEpitopesErythrocytesFluorescent Antibody TechniqueHumansMiceReceptors, Complement 3bRecombinant ProteinsTransfectionAntibodies, MonoclonalCR1 protein, humanEpitopesReceptors, Complement 3bRecombinant Proteins

Identifiers

PMID17493021
PMCPMC1941935
OpenAlexW1566842563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.